Axigluon Couplings in the Presence of Extra Color-Octet Spin-One Fields

In this paper, we study how the interaction of the axigluon with quarks is modified when we introduce new color-octet spin-one fields in a chiral color model. We show that in this case the strength of this interaction is not completely determined by the gauge symmetry any more and can be significantly weaker than the one predicted in the original chiral color model. In this way, we reinterpret the non-observability of the axigluon at the Tevatron, not as a limit on the axigluon mass, but as a limit on the strength of the axigluon coupling to quarks

Realistic constraints on the doubly charged bilepton couplings from Bhabha scattering with LEP data

Upper limits on doubly charged bilepton couplings and masses are extracted from LEP data for Bhabha scattering at energy range $\sqrt{s}=183-202$ GeV using standard model program ZFITTER which calculates radiative corrections. We find that $g_{L}^{2}/M_{L}^{2}<O(10^{-5})GeV^{-2}$ at 95% C.L. for scalar and vector bileptons.Comment: 5 pages, 1 EPS figur

Explaining the Higgs Decays at the LHC with an Extended Electroweak Model

We show that the recent discovery of a new boson at the LHC, which we assume to be a Higgs boson, and the observed enhancement in its diphoton decays compared to the SM prediction, can be explained by a new doublet of charged vector bosons from an extended electroweak gauge sector model with SU(3)_C\otimesSU(3)_L\otimesU(1)_X symmetry. Our results show a good agreement between our theoretical expected sensitivity to a 126--125 GeV Higgs boson and the experimental significance observed in the diphoton channel at the 8 TeV LHC. Effects of an invisible decay channel for the Higgs boson are also taken into account, in order to anticipate a possible confirmation of deficits in the branching ratios into $ZZ^*$, $WW^*$, bottom quarks, and tau leptons.Comment: 16 pages, 5 figure

Two-body Z′Z' decays in the minimal 331 model

The two-body decays of the extra neutral boson Z_2 predicted by the minimal 331 model are analyzed. At the three-level it can decay into standard model particles as well as exotic quarks and the new gauge bosons predicted by the model. The decays into a lepton pair are strongly suppressed, with $Br(Z_2 --> l^+l^-) ~ 10^{-2}$ and $Br(Z_2 --> \bar{\nu}_l \nu) ~ 10^{-3}$. In the bosonic sector, Z_2 would decay mainly into a pair of bilepton gauge bosons, with a branching ratio below the 0.1 level. The Z_2 boson has thus a leptophobic and bileptophobic nature and it would decay dominantly into quark pairs. The anomaly-induced decays $Z_2 --> Z_1\gamma$ and $Z_2 --> Z_1Z_1$, which occurs at the one-loop level are studied. It is found that $Br(Z_2 --> Z_1\gamma) ~ 10^{-9}$ and $Br(Z_2 --> Z_1Z_1) ~ 10^{-6}$ at most. As for the $Z_2 --> W^+W^-$ and $Z_2 --> Z_1H$ decays, with H a relatively light Higgs boson, they are induced via Z'-Z mixing. It is obtained that $Br(Z_2 --> W^+W^-) ~ 10^{-2}$ and $Br (Z_2 --> Z_1H) ~ 10^{-5}$. We also examine the flavor changing neutral current decays $Z_2 --> tc$ and $Z_2 --> tu$, which may have branching fractions as large as $10^{-3}$ and $10^{-5}$, respectively, and thus may be of phenomenological interest.Comment: 14 pages, 3 figures, submitted to Physical Review

Static quantities of the W boson in the SU_L(3) X U_X(1) model with right-handed neutrinos

The static electromagnetic properties of the $W$ boson, $\Delta \kappa$ and $\Delta Q$, are calculated in the SU_L(3)} \times U_X(1) model with right-handed neutrinos. The new contributions from this model arise from the gauge and scalar sectors. In the gauge sector there is a new contribution from a complex neutral gauge boson $Y^0$ and a singly-charged gauge boson $Y^\pm$. The mass of these gauge bosons, called bileptons, is expected to be in the range of a few hundreds of GeV according to the current bounds from experimental data. If the bilepton masses are of the order of 200 GeV, the size of their contribution is similar to that obtained in other weakly coupled theories. However the contributions to both $\Delta Q$ and $\Delta \kappa$ are negligible for very heavy or degenerate bileptons. As for the scalar sector, an scenario is examined in which the contribution to the $W$ form factors is identical to that of a two-Higgs-doublet model. It is found that this sector would not give large corrections to $\Delta \kappa$ and $\Delta Q$.Comment: New material included. Final version to apppear in Physical Review

Seismology of the Sun : Inference of Thermal, Dynamic and Magnetic Field Structures of the Interior

Recent overwhelming evidences show that the sun strongly influences the Earth's climate and environment. Moreover existence of life on this Earth mainly depends upon the sun's energy. Hence, understanding of physics of the sun, especially the thermal, dynamic and magnetic field structures of its interior, is very important. Recently, from the ground and space based observations, it is discovered that sun oscillates near 5 min periodicity in millions of modes. This discovery heralded a new era in solar physics and a separate branch called helioseismology or seismology of the sun has started. Before the advent of helioseismology, sun's thermal structure of the interior was understood from the evolutionary solution of stellar structure equations that mimicked the present age, mass and radius of the sun. Whereas solution of MHD equations yielded internal dynamics and magnetic field structure of the sun's interior. In this presentation, I review the thermal, dynamic and magnetic field structures of the sun's interior as inferred by the helioseismology.Comment: To be published in the proceedings of the meeting "3rd International Conference on Current Developments in Atomic, Molecular, Optical and Nano Physics with Applications", December 14-16, 2011, New Delhi, Indi

Patient satisfaction after biofeedback for constipation and pelvic floor dyssynergia.

Patients referred for chronic constipation frequently report symptoms of straining, feeling of incomplete evacuation, or the need to facilitate defecation digitally (dyschezia). When such patients show manometric evidence of inappropriate contraction or failure to relax the pelvic floor muscles during attempts to defecate, they are diagnosed as having pelvic floor dyssynergia (Rome I). To evaluate long-term satisfaction of patients with pelvic floor dyssynergia after biofeedback. Forty-one consecutive patients referred for chronic constipation at an outpatient gastrointestinal unit and diagnosed as having pelvic floor dyssynergia who completed a full course of biofeedback. Data have been collected using a standardised questionnaire. A questionnaire survey of patients' satisfaction rate and requirement of aperients was undertaken. Mean age and symptom duration were respectively 41 and 20 years. Half of patients reported fewer than 3 bowel motions per week. Patients were treated with a mean of 5 biofeedback sessions. At the end of the therapy pelvic floor dyssynergia was alleviated in 85% of patients and 49% were able to stop all aperients. Satisfaction was maintained at follow-up telephone interviews undertaken after a mean period of 2 years, as biofeedback was helpful for 79% of patients and 47% still abstained from intake of aperients. Satisfaction after biofeedback is high for patients referred for chronic constipation and diagnosed with pelvic floor dyssynergia. Biofeedback improves symptoms related to dyschezia and reduces use of aperients

Effects of rosuvastatin on progression of stenosis in adult patients with congenital aortic stenosis (PROCAS Trial)

Item does not contain fulltextRecent trials have failed to show that statin therapy halts the progression of calcific aortic stenosis (AS). We hypothesized that statin therapy in younger patients with congenital AS would be more beneficial, because the valve is less calcified. In the present double-blind, placebo-controlled trial, 63 patients with congenital AS (age 18 to 45 years) were randomly assigned to receive either 10 mg of rosuvastatin daily (n = 30) or matched placebo (n = 33). The primary end point was the progression of peak aortic valve velocity. The secondary end points were temporal changes in the left ventricular mass, ascending aortic diameter, and N-terminal pro-brain natriuretic peptide (NT-proBNP). The median follow-up was 2.4 years (interquartile range 1.9 to 3.0). The mean increase in peak velocity was 0.05 +/- 0.21 m/s annually in the rosuvastatin group and 0.09 +/- 0.24 m/s annually in the placebo group (p = 0.435). The annualized change in the ascending aorta diameter (0.4 +/- 1.7 mm with rosuvastatin vs 0.5 +/- 1.6 mm with placebo; p = 0.826) and left ventricular mass (1.1 +/- 15.8 g with rosuvastatin vs -3.7 +/- 30.9 g with placebo; p = 0.476) were not significantly different between the 2 groups. Within the statin group, the NT-proBNP level was 50 pg/ml (range 19 to 98) at baseline and 21 pg/ml (interquartile range 12 to 65) at follow-up (p = 0.638). NT-proBNP increased from 40 pg/ml (interquartile range 20 to 92) to 56 pg/ml (range 26 to 130) within the placebo group (p = 0.008). In conclusion, lipid-lowering therapy with rosuvastatin 10 mg did not reduce the progression of congenital AS in asymptomatic young adult patients. Interestingly, statins halted the increase in NT-proBNP, suggesting a potential positive effect of statins on cardiac function in young patients with congenital AS